Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-upRichard A. Larson, H. Kantarjian, Gabriel Étienne et al.|Leukemia|2012Cited by 440
Final Report: Somatic Mutations and HMGCLL1 Haplotype Are Not Associated with Molecular Relapse-Free Survival in Patients with Chronic Myeloid Leukemia Who Attempt Treatment-Free RemissionMaría Agustina Perusini, Dennis Dong Hwan Kim, Kátia Bórgia Barbosa Pagnano et al.|Blood|2023Cited by 0